No abstract

Introduction Women diagnosed with female sexual interest/arousal disorder (FSIAD) report lower health-related quality of life, more depressive symptoms, and lower sexual and relationship satisfaction compared with healthy control subjects. Despite the impact of FSIAD on women’s sexuality and the inherently interpersonal nature of the sexual problem, it remains unclear whether the partners of women with FSIAD also face negative consequences, as seen in other sexual dysfunctions. Aim The aim of this study was to compare the sexual, relational, and psychological functioning of partners of women with FSIAD (as well as the women themselves) to their control counterparts. We also compared women with their partners within the FSIAD and control groups. Methods Woman diagnosed with FSIAD and their partners (n = 97) and control couples (n = 108) independently completed measures of sexual desire, sexual distress, sexual function, sexual satisfaction, sexual communication, relationship satisfaction, depression, and anxiety. Main Outcome Measure Main outcomes included: Sexual Desire Inventory-2; Female Sexual Distress Scale; Female Sexual Functioning Index; International Index of Erectile Functioning (IIEF), Global Measure of Sexual Satisfaction; Dyadic Sexual Communication Scale; Couple Satisfaction Index; Beck Depression Inventory-II; State-Trait Anxiety Inventory-Short Form. Results Partners of women with FSIAD reported lower sexual satisfaction, poorer sexual communication, and higher sexual distress compared with control partners. Male partners of women with FSIAD reported more difficulties with orgasmic and erectile functioning and lower overall satisfaction and intercourse satisfaction on the IIEF compared with control partners. Women with FSIAD reported lower sexual desire and satisfaction, and higher sexual distress and depressive and anxiety symptoms, in comparison to both control women and their own partners, and they reported poorer sexual communication compared with control women. Women with FSIAD also reported lower sexual desire, arousal, lubrication, and satisfaction, and greater pain during intercourse on the Female Sexual Function Index compared with control women. Clinical Implications The partners of women with FSIAD also experience negative consequences—primarily in the domain of sexuality. Partners should be included in treatment and future research. Strength & Limitations This is the first study, to our knowledge, to document consequences for partners of women with FSIAD in comparison to control subjects. This study is cross-sectional, and causation cannot be inferred. Most couples were in mixed-sex relationships and identified as straight and cis-gendered; results may not generalize. Conclusion Findings suggest that partners of women with FSIAD experience disruptions to many aspects of their sexual functioning, as well as lower overall sexual satisfaction and heightened sexual distress.

No abstract

Vulvodynia, an idiopathic chronic vulvar pain, is a prevalent genital pain condition that results in significant impairment to sexual, relational, and psychological functioning of affected women and their romantic partners. Despite its high prevalence, there remain gaps in knowledge and health care access for women coping with vulvodynia, given its varied clinical presentation and no widely accepted treatment protocol. The past several decades have seen important advancements in understanding vulvodynia and developing effective treatments; however, progress has been impeded due to clinical and methodological challenges in conducting research with this vulnerable population. This review presents a brief overview of vulvodynia correlates, consequences, etiology, and treatment, and then turns its attention to considering the clinical and methodological challenges that hinder vulvodynia research. Identifying these barriers alongside potential mitigating solutions is essential to developing empirically supported treatments for all women affected by vulvodynia, across all age and minority groups. Potential solutions will require researchers to broaden eligibility criteria, examine subgroups of women, and expand definitions of treatment outcomes, and may be best facilitated by more active collaboration among research groups and across relevant disciplines. Engagement in these solutions may contribute to more representative findings and the development and dissemination of empirically based treatment options for this complex pain condition.